EXABLATE NEURO APPROVED BY ISRAELI MINISTRY OF HEALTH FOR NON-INVASIVE TREATMENT OF NEUROLOGICAL DISORDERS
ExAblate Neuro approved by Israeli Ministry of Health for non-invasive treatment of neurological disorders
Tirat Carmel (Oct. 3, 2013). INSIGHTEC Ltd. announced that the Israeli Ministry of Health has approved ExAblate Neuro for the treatment of neurological movement disorders including Essential Tremor and tremor-dominant Parkinson’s disease. ExAblate Neuro uses MR guided Focused Ultrasound, pioneered by INSIGHTEC, to treat these disorders non-invasively deep inside the brain.
The approval is based on studies that were published in the New England Journal of Medicine, Lancet Neurology and the Journal of Neurosurgery.
INSIGHTEC expects that Rambam Medical Center and Sheba Medical Center will begin to provide treatments during 2013.